ECOVYST INC (ECVT) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:ECVT • US27923Q1094

11.05 USD
+0.31 (+2.89%)
At close: Feb 6, 2026
11.05 USD
0 (0%)
After Hours: 2/6/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

ECVT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. The financial health of ECVT is average, but there are quite some concerns on its profitability. ECVT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year ECVT was profitable.
  • ECVT had a positive operating cash flow in the past year.
  • In multiple years ECVT reported negative net income over the last 5 years.
  • In the past 5 years ECVT always reported a positive cash flow from operatings.
ECVT Yearly Net Income VS EBIT VS OCF VS FCFECVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

  • With a Return On Assets value of -6.16%, ECVT is not doing good in the industry: 75.90% of the companies in the same industry are doing better.
  • ECVT's Return On Equity of -17.58% is on the low side compared to the rest of the industry. ECVT is outperformed by 72.29% of its industry peers.
  • ECVT has a Return On Invested Capital of 4.78%. This is comparable to the rest of the industry: ECVT outperforms 57.83% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ECVT is in line with the industry average of 6.09%.
Industry RankSector Rank
ROA -6.16%
ROE -17.58%
ROIC 4.78%
ROA(3y)2.47%
ROA(5y)-1.71%
ROE(3y)6.52%
ROE(5y)-4.23%
ROIC(3y)5.69%
ROIC(5y)4.4%
ECVT Yearly ROA, ROE, ROICECVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • The Operating Margin of ECVT (11.78%) is better than 63.86% of its industry peers.
  • In the last couple of years the Operating Margin of ECVT has grown nicely.
  • Looking at the Gross Margin, with a value of 24.21%, ECVT is in line with its industry, outperforming 43.37% of the companies in the same industry.
  • ECVT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.78%
PM (TTM) N/A
GM 24.21%
OM growth 3Y11.88%
OM growth 5Y1.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.35%
GM growth 5Y-1.84%
ECVT Yearly Profit, Operating, Gross MarginsECVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • ECVT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ECVT has been increased compared to 1 year ago.
  • Compared to 5 years ago, ECVT has less shares outstanding
  • The debt/assets ratio for ECVT is higher compared to a year ago.
ECVT Yearly Shares OutstandingECVT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ECVT Yearly Total Debt VS Total AssetsECVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 1.16, we must say that ECVT is in the distress zone and has some risk of bankruptcy.
  • ECVT has a Altman-Z score of 1.16. This is in the lower half of the industry: ECVT underperforms 73.49% of its industry peers.
  • ECVT has a debt to FCF ratio of 11.56. This is a negative value and a sign of low solvency as ECVT would need 11.56 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 11.56, ECVT perfoms like the industry average, outperforming 57.83% of the companies in the same industry.
  • A Debt/Equity ratio of 1.39 is on the high side and indicates that ECVT has dependencies on debt financing.
  • The Debt to Equity ratio of ECVT (1.39) is worse than 73.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF 11.56
Altman-Z 1.16
ROIC/WACC0.42
WACC11.35%
ECVT Yearly LT Debt VS Equity VS FCFECVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • ECVT has a Current Ratio of 2.25. This indicates that ECVT is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.25, ECVT is doing good in the industry, outperforming 62.65% of the companies in the same industry.
  • ECVT has a Quick Ratio of 2.07. This indicates that ECVT is financially healthy and has no problem in meeting its short term obligations.
  • ECVT has a Quick ratio of 2.07. This is in the better half of the industry: ECVT outperforms 79.52% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 2.07
ECVT Yearly Current Assets VS Current LiabilitesECVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • ECVT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.38%, which is quite good.
  • Measured over the past years, ECVT shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.01% on average per year.
  • ECVT shows a small growth in Revenue. In the last year, the Revenue has grown by 7.74%.
  • ECVT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.75% yearly.
EPS 1Y (TTM)15.38%
EPS 3Y4.38%
EPS 5Y-9.01%
EPS Q2Q%35.71%
Revenue 1Y (TTM)7.74%
Revenue growth 3Y4.85%
Revenue growth 5Y5.75%
Sales Q2Q%14.34%

3.2 Future

  • Based on estimates for the next years, ECVT will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.54% on average per year.
  • The Revenue is expected to grow by 4.37% on average over the next years.
EPS Next Y-15.66%
EPS Next 2Y3.18%
EPS Next 3Y13.73%
EPS Next 5Y11.54%
Revenue Next Year4.5%
Revenue Next 2Y2.7%
Revenue Next 3Y4.04%
Revenue Next 5Y4.37%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ECVT Yearly Revenue VS EstimatesECVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
ECVT Yearly EPS VS EstimatesECVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.42 indicates a rather expensive valuation of ECVT.
  • Based on the Price/Earnings ratio, ECVT is valued a bit cheaper than 61.45% of the companies in the same industry.
  • ECVT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.92.
  • A Price/Forward Earnings ratio of 17.90 indicates a rather expensive valuation of ECVT.
  • 60.24% of the companies in the same industry are more expensive than ECVT, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 27.78. ECVT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.42
Fwd PE 17.9
ECVT Price Earnings VS Forward Price EarningsECVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ECVT's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, ECVT is valued a bit cheaper than the industry average as 74.70% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.04
EV/EBITDA 11.84
ECVT Per share dataECVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ECVT's earnings are expected to grow with 13.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.18%
EPS Next 3Y13.73%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ECVT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ECOVYST INC

NYSE:ECVT (2/6/2026, 8:04:00 PM)

After market: 11.05 0 (0%)

11.05

+0.31 (+2.89%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-04
Earnings (Next)02-25
Inst Owners105.99%
Inst Owner Change-0.39%
Ins Owners1.47%
Ins Owner Change-0.37%
Market Cap1.26B
Revenue(TTM)749.19M
Net Income(TTM)-106.87M
Analysts81.67
Price Target11.9 (7.69%)
Short Float %4.16%
Short Ratio3.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.02%
Min EPS beat(2)19.79%
Max EPS beat(2)20.26%
EPS beat(4)4
Avg EPS beat(4)45.97%
Min EPS beat(4)15.13%
Max EPS beat(4)128.72%
EPS beat(8)4
Avg EPS beat(8)16.25%
EPS beat(12)7
Avg EPS beat(12)11.96%
EPS beat(16)10
Avg EPS beat(16)10.9%
Revenue beat(2)0
Avg Revenue beat(2)-2.57%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)-1.89%
Revenue beat(4)0
Avg Revenue beat(4)-4.59%
Min Revenue beat(4)-7.53%
Max Revenue beat(4)-1.89%
Revenue beat(8)0
Avg Revenue beat(8)-4.28%
Revenue beat(12)0
Avg Revenue beat(12)-4.7%
Revenue beat(16)4
Avg Revenue beat(16)-2.38%
PT rev (1m)0%
PT rev (3m)-4.11%
EPS NQ rev (1m)-16.05%
EPS NQ rev (3m)-24.71%
EPS NY rev (1m)-4.02%
EPS NY rev (3m)-3.69%
Revenue NQ rev (1m)-2.94%
Revenue NQ rev (3m)-3.97%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)-2.7%
Valuation
Industry RankSector Rank
PE 18.42
Fwd PE 17.9
P/S 1.68
P/FCF 17.04
P/OCF 8.84
P/B 2.07
P/tB 5.76
EV/EBITDA 11.84
EPS(TTM)0.6
EY5.43%
EPS(NY)0.62
Fwd EY5.59%
FCF(TTM)0.65
FCFY5.87%
OCF(TTM)1.25
OCFY11.31%
SpS6.57
BVpS5.33
TBVpS1.92
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.48
Profitability
Industry RankSector Rank
ROA -6.16%
ROE -17.58%
ROCE 5.51%
ROIC 4.78%
ROICexc 5.04%
ROICexgc 6.77%
OM 11.78%
PM (TTM) N/A
GM 24.21%
FCFM 9.87%
ROA(3y)2.47%
ROA(5y)-1.71%
ROE(3y)6.52%
ROE(5y)-4.23%
ROIC(3y)5.69%
ROIC(5y)4.4%
ROICexc(3y)6.1%
ROICexc(5y)4.71%
ROICexgc(3y)9.02%
ROICexgc(5y)6.89%
ROCE(3y)6.55%
ROCE(5y)5.06%
ROICexgc growth 3Y19.33%
ROICexgc growth 5Y28.08%
ROICexc growth 3Y19.89%
ROICexc growth 5Y30.34%
OM growth 3Y11.88%
OM growth 5Y1.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.35%
GM growth 5Y-1.84%
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF 11.56
Debt/EBITDA 5.01
Cap/Depr 85.17%
Cap/Sales 9.16%
Interest Coverage 1.89
Cash Conversion 84.46%
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 2.07
Altman-Z 1.16
F-Score4
WACC11.35%
ROIC/WACC0.42
Cap/Depr(3y)76.28%
Cap/Depr(5y)73.6%
Cap/Sales(3y)8.81%
Cap/Sales(5y)11.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.38%
EPS 3Y4.38%
EPS 5Y-9.01%
EPS Q2Q%35.71%
EPS Next Y-15.66%
EPS Next 2Y3.18%
EPS Next 3Y13.73%
EPS Next 5Y11.54%
Revenue 1Y (TTM)7.74%
Revenue growth 3Y4.85%
Revenue growth 5Y5.75%
Sales Q2Q%14.34%
Revenue Next Year4.5%
Revenue Next 2Y2.7%
Revenue Next 3Y4.04%
Revenue Next 5Y4.37%
EBIT growth 1Y-11.22%
EBIT growth 3Y17.3%
EBIT growth 5Y7.72%
EBIT Next Year32.58%
EBIT Next 3Y17%
EBIT Next 5Y14.46%
FCF growth 1Y-4.82%
FCF growth 3Y5.01%
FCF growth 5Y-10.41%
OCF growth 1Y-5.41%
OCF growth 3Y4.89%
OCF growth 5Y-10.96%

ECOVYST INC / ECVT FAQ

What is the ChartMill fundamental rating of ECOVYST INC (ECVT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ECVT.


Can you provide the valuation status for ECOVYST INC?

ChartMill assigns a valuation rating of 4 / 10 to ECOVYST INC (ECVT). This can be considered as Fairly Valued.


What is the profitability of ECVT stock?

ECOVYST INC (ECVT) has a profitability rating of 3 / 10.


What is the financial health of ECOVYST INC (ECVT) stock?

The financial health rating of ECOVYST INC (ECVT) is 4 / 10.


Can you provide the expected EPS growth for ECVT stock?

The Earnings per Share (EPS) of ECOVYST INC (ECVT) is expected to decline by -15.66% in the next year.